
The Viral Immunity and Immunopathology Laboratory at @Hudson_Research @CiiiD_Research Host-directed therapies for #influenza and pulmonary inflammation
Melbourne, Australia
Joined March 2023
- Tweets45
- Following129
- Followers109
- Likes174
Although there are no effective drugs for severe influenza, a breakthrough led by @Tate_Lab in collaboration with Associate Professor Ashley Mansell, led to innovative treatments that target the body rather than the virus itself to limit inflammation and save lives.
Read more in NHMRC’s 10 of the Best 17th Edition now on our website: ow.ly/yTS850YJiFC
Tate_Lab retweeted
Exciting news! The AVS12 Meeting Report is now published in the @ASMicrobiology Journal of Virology 🎉
AVS prides itself on supporting all voices in virology through career development, Indigenous engagement, collaboration, and recognition of excellence.
journals.asm.org/doi/10.1128…
Tate_Lab retweeted
🚨 Registrations for #AVS12 are still open! 🚨
📅 Dec 2-5 | 📍 RACV Goldfields, Creswick, VIC
Join us for an unforgettable event!
🔗 Register now: avs2024.org
Tate_Lab retweeted
Taking AIM at Influenza: The Role of the AIM2 Inflammasome
✍️by Xu & Tate
👉mdpi.com/1999-4915/16/10/153…
#influenza #sensing #immunology
Tate_Lab retweeted
Options for the control of influenza XII Conference #optionsxii2024 Brisbane
Tate_Lab retweeted
Join us this December for AVS2024! Early Bird Registration & Abstract deadline is Friday 9th August
Stay Posted here: avs2024.org
Tate_Lab retweeted
When patients with severe flu are admitted to hospital there are no effective drugs available to reduce the response to the virus. Our researchers are focusing on finding treatments to help these patients
2024 flu season guide: bit.ly/4dWolB5
@Tate_Lab @CiiiD_Research
Tate_Lab retweeted
Thrilled to be receiving this award!
Massive thanks to the @Lungfoundation and @Tate_Lab for all the support!
#TSANZRS2024
Tate_Lab retweeted
Lung Foundation Australia's Hope Research Fund grants for 2024 have been awarded! We would like to offer our congratulations to the early and mid-career PHDs and fellowships awardees 👏
Tate_Lab retweeted
We are pleased to announce our April #ACDS Seminar will feature @Sarah_Rosli_ @Hudson_Research & Dr Robson Kriiger Loterio @BurnetInstitute! 👏
Join us on Wed 3rd April (11am AEDT on Zoom) to hear how GSDME alters #influenza severity 🫁 and how Coxiella stops host #celldeath! 🦠
Tate_Lab retweeted
Save the date for AVS 2024
2nd– 5th December
RACV Goldfields, Creswick, VIC
Stay Posted here: avs2024.org/
Tate_Lab retweeted
Congratulations to @DrEmilyGulliver from @Forster_Lab on winning best ECR talk and @Sarah_Rosli_ from @Tate_Lab for winning best student poster at #lorneiandi! What a great meeting which showcased so much of the exciting research ongoing here at CiiiD & @Hudson_Research ! 👏
Tate_Lab retweeted
A/Prof Michelle Tate, PhD student Sarah Rosli & their team have identified a protein, Gasdermin D, in lung epithelial cells which promotes hyper-inflammation & cell death in severe cases of #Influenza. 🫁 Read more: bit.ly/3uRQXZY
Tate_Lab retweeted
This was a terrific effort co-led by @NollaigBourke, a PhD for @ZoeMarks16 and post doc @nk_campbell and many more from @CiiiD_Hudson. Invaluable collab with @ProfClareScott team, @PeterMacCC colleagues @parkerlabPMCC and others @Hudson_Research nature.com/articles/s41586-0…
Tate_Lab retweeted
Join us at our #StudentOpenDay for an insight into why you should consider starting your career alongside our more than 170 Honours, Masters & PhD #Students.
📆 Monday, 28 August 2022
⏰ 5:30-7:00pm
📍 JOIN US ONLINE | Register to receive Zoom link: bit.ly/3qe6em0
Tate_Lab retweeted
NEW article describing ADS032, the first dual inhibitor of NLRP1 and NLRP3, its effects on inflammasome formation and its potential as treatment for inflammatory diseases associated with NLRP1 and 3. @CiiiD_Hudson @EdinburghUni @AdisoTx @ASImmunology
onlinelibrary.wiley.com/doi/…
Tate_Lab retweeted
We’re proud to announce the publication of a research article in @ClinTransImmuno describing the ADS032 mechanism of action as a novel dual inflammasome inhibitor of both NLRP 1 and NLRP 3 for the modulation of #inflammation. Learn more: bit.ly/3psDCoY
Tate_Lab retweeted
Over the past decade there has been a rise in hospitalisations and deaths due to #Influenza (#Flu). 🦠🤧
Read more or donate before 30 June 2023: bit.ly/451XwqI
@Tate_Lab
@DrChrisHarpur
@CiiiD_Research
Tate_Lab retweeted
Cutting edge medical research projects for #Influenza (#Flu) & #PelvicOrganProlapse, (#POP) have received funding from the 2023 Victorian Medical Research Acceleration Fund! 🙌
Read about A/Prof Michelle Tate (left) & Dr Shayanti Mukherjee's (right) work: bit.ly/41ilavR
Tate_Lab retweeted
In a letter written by committee members of the Australasian Virology Society and co-signed by 121 virologists, we agree with and Support “Virology under the Microscope—a Call for Rational Discourse”. Copublished today @mbiojournal @JVirology @mSphereJ 1/7 journals.asm.org/doi/10.1128…





























